Pentwater Capital Management LP has recently announced that it has increased stake in Renalytix Plc ADR (NASDAQ:RNLX) by 19.69%. After grabbing 0.6 million shares, the institutional investor is now in possession of 98440.0 shares of the Healthcare Company. The new investment brought the stake of investor firm to 1.23% having worth around $0.28 million. Moreover, Allspring Global Investments LLC increased its share by 0.34 million to have a control over 0.34 million shares. And Corient Private Wealth LLC raised its holdings to 0.11 million shares by acquiring 0.34 million shares or 0.69% of the stake.
Renalytix Plc ADR (RNLX) concluded trading on 01/10/24 at a closing price of $0.34, with 3.25 million shares of worth about $1.1 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -91.45% during that period and on Wednesday the price saw a loss of about -14.94%. Currently the company’s common shares owned by public are about 46.89M shares, out of which, 46.30M shares are available for trading.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
JNL Multi-Manager Small Cap Growt, Leadersel – Innotech ESG, and Balaguer 98 de Inversiones, SICAV are the top 3 mutual funds which are holding stakes in Renalytix Plc ADR JNL Multi-Manager Small Cap Growt is currently holding 0.13 million shares of worth totaling $60060.0. The company recently came buying 0.13 million shares which brought its stake up to 0.26% of the company’s outstanding shares. Leadersel – Innotech ESG sold 7725.0 shares, after which its hold over company’s outstanding shares shrunk to 0.19%, leaving 92275.0 shares with the mutual fund that have a worth of about $43831.0. Balaguer 98 de Inversiones, SICAV, after buying 30002.0 shares, have now control over 0.06% of the stake in the company. It holds 15633.0 shares of worth $14251.0.
Renalytix Plc ADR (NASDAQ: RNLX) started trading at $0.374, below -$0.03 from concluding price of the previous day. However, the stock later moved at a day high price of 0.3798, or with a loss of -14.94%. Stock saw a price change of -25.48% in past 5 days and over the past one month there was a price change of -22.09%. Year-to-date (YTD), RNLX shares are showing a performance of -12.10% which decreased to -86.18% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $0.30 but also hit the highest price of $4.04 during that period. The average intraday trading volume for Renalytix Plc ADR shares is 129.97K. The stock is currently trading -15.08% below its 20-day simple moving average (SMA20), while that difference is down -40.93% for SMA50 and it goes to -81.99% lower than SMA200.
Pentwater Capital Management LP acquired 0.6 million shares of Renalytix Plc ADR having value of about $0.28 million. Data submitted at the U.S SEC by Pentwater Capital Management LP revealed that the firm now holds 98440.0 shares in the company valued at close to $33469.6, or have control over 19.69% stake in the company. Renalytix Plc ADR (NASDAQ: RNLX) currently have 46.89M outstanding shares and institutions hold larger chunk of about 17.81% of that. Holding of mutual funds in the company is about 0.61% while other institutional holders and individual stake holders have control over 17.65% and — of the stake respectively.
The stock has a current market capitalization of $17.13M and its 3Y-monthly beta is at 2.11. It has posted earnings per share of -$1.01 in the same period. It has Quick Ratio of 1.09. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for RNLX, volatility over the week remained 10.33% while standing at 15.62% over the month.
Analysts are in expectations that Renalytix Plc ADR (RNLX) stock would likely to be making an EPS of $Renalytix plc in the current quarter, while forecast for next quarter EPS is $0.34 and it is $Stocks for next year. For the current quarter EPS, analysts have given the company a lowest target $RLX Technology Inc. which is $RELX PLC PLC at the higher side of the target for the same. When we compare those targets with actual EPS, we find that company posted an EPS of $Genelux Corporation in the same quarter a year ago. Stock’s fiscal year EPS is expected to rise by 32.75% while it is estimated to increase by 29.72% in next year.
Analysts at 3 brokerage firms have issued recommendations for the Renalytix Plc ADR (RNLX)’s stock and average of those rates the stock at a “Strong Buy” and assign it a score of 1.00. Out of those 3 Wall Street analysts, 3 recommended a “Buy” rating, while 0 were in favor recommending the stock as a “Hold” and 0 analyst recommended the stock as “Sell”.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by H.C. Wainwright on January 18, 2022 offering a Buy rating for the stock and assigned a target price of $30 to it.
